Study title: Platelet aggregation Inhibition in Children On Clopidogrel (PICOLO) – Doseranging pharmacodynamic assessment of platelet aggregation inhibition with clopidogrel in children of Blalock-Taussig shunt age categories (neonates and infants/toddlers)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Hemic and Lymphatic Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CLOPIDROGEL | |||||
ATC code: | |||||
Document link: Clopidogrel-Study 1.pdf | |||||
Document date: 2011-09-22 | |||||
Study number: PDY4422 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | Y | - | - |